Ado-trastuzumab emtansine Intravenous and Glatiramer Acetate
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Glatiramer Acetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Glatiramer injection
- Ado-trastuzumab emtansine Intravenous-Glatiramer Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Glatopa
- Ado-trastuzumab emtansine Intravenous-Glatopa injection
- Ado-trastuzumab emtansine Intravenous-Glecaprevir and pibrentasvir
- Ado-trastuzumab emtansine Intravenous-Gleevec
- Glatiramer Acetate-Adox Pak 2/100
- Glatiramer Acetate-Adoxa
- Glatiramer Acetate-Adoxa CK
- Glatiramer Acetate-Adoxa Pak
- Glatiramer Acetate-Adoxa Pak 1/100
- Glatiramer Acetate-Adoxa Pak 1/150